The company said that the peanut butter was sold nationwide and the recall includes more than 45 kinds of products. 

The Food and Drug Administration’s authorization now opens a third shot to elementary-age kids, too — at least five months after their last dose. There is one more hurdle: The Centers for Disease Control and Prevention must decide whether to formally recommend the booster for this age group.

The White House said it is working with all major formula producers to boost production, including reaching out to their suppliers to encourage them to prioritize production and delivery of formula ingredients. 

Months of spot shortages at pharmacies and supermarkets have been exacerbated by the recall at Abbott, which was forced to shutter its largest U.S. formula manufacturing plant in February due to contamination concerns.

The meeting announcement follows months of frustration from families impatient for a chance to vaccinate their little children, along with complaints from politicians bemoaning the slow pace of the process.

Menthol accounts for more than a third of cigarettes sold in the U.S, and the mint flavor is favored by Black smokers and young people. Menthol’s cooling effect has been shown to mask the throat harshness of smoking, making it easier to start and harder to quit.

The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage, the FDA said, and can be used in doctor’s offices, hospitals and mobile testing sites. 

The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines to those age 50 or over at least four months after their previous booster.

The US Food and Drug Administration could decide in the coming days to take steps to curb the use of antibody treatments produced by Eli Lilly and Regeneron, the source said, pointing to the growing body of evidence that shows their monoclonal therapies don't effectively neutralize the virus’ omicron variant.

U.S. regulators on Friday shortened the time that people who received Moderna's COVID-19 vaccine have to wait for a booster — to five months rather than six.

The Centers for Disease Control and Prevention's advisers voted that a booster was safe for younger teens and should be offered to them once enough time — five months — has passed since their last shot.

Boosters already are recommended for everyone 16 and older, and federal regulators on Monday decided they’re also warranted for 12- to 15-year-olds once enough time has passed since their last dose.

The Food and Drug Administration announcement on Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. 

The U.S. and many other nations already were urging adults to get booster shots to pump up immunity that can wane months after vaccination, calls that intensified with the discovery of the worrisome new omicron variant.

The Food and Drug Administration panel voted 13-10 that the antiviral drug’s benefits outweigh its risks, including potential birth defects if used during pregnancy.

The Centers for Disease Control and Prevention must agree to expand Pfizer and Moderna boosters to even healthy young adults. Its scientific advisers were set to debate later Friday.